{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:55:04Z","timestamp":1783022104051,"version":"3.54.6"},"reference-count":122,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Dry eye disease (DED) is a complex, multifactorial, progressive disease that has consequences both for individuals and society. Symptoms reported by patients include discomfort in the eye and periodic blurred vision, while in the broader perspective, the disease is associated with economic burdens and challenges for healthcare systems. Globally, dry eye disease remains a growing problem observed in many countries. It is estimated that symptoms of dry eye syndrome occur in approximately 10 to 20 per cent of people over the age of 40. This prevalence is on the rise, which is associated with both the aging population and increased incidence among younger adults. In this group, factors such as contact lens wear and prolonged use of digital devices are considered to be contributing factors. Further epidemiological studies, conducted in different regions of the world, covering diverse populations and a wide range of age groups, with a particular focus on younger cohorts, may contribute to a more accurate understanding of the prevalence of dry eye disease. There are more and more methods of diagnosing DED. In addition to well-known procedures like the Schirmer test or tear break-up time, there are also methods that focus on the evaluation of the tear film or imaging of the ocular surface. Moreover, usage of artificial intelligence is also playing a significant role in it. However, the key issue in individual cases is introducing the most effective treatment based on combining available substances, including corticosteroids, antibiotics and supplements, which leads to a reduction in inflammation and improvement in visual comfort.<\/jats:p>","DOI":"10.3390\/jcm15072535","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:48:41Z","timestamp":1774532921000},"page":"2535","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dry Eye Disease: From Mechanisms to Management and Future Directions"],"prefix":"10.3390","volume":"15","author":[{"given":"Zofia","family":"Pniakowska","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Vision Rehabilitation, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"},{"name":"Optegra Eye Clinic, Ul. Skladowa 35, 90-127 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7090-259X","authenticated-orcid":false,"given":"Natasza","family":"Kurys","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Rehabilitation, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7626-2996","authenticated-orcid":false,"given":"Hanna","family":"Pietruszewska","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Rehabilitation, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3265-2826","authenticated-orcid":false,"given":"Aleksandra","family":"Przybylak","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Rehabilitation, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Jurowski","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Rehabilitation, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Britten-Jones, A.C., Wang, M.T.M., Samuels, I., Jennings, C., Stapleton, F., and Craig, J.P. (2024). Epidemiology and Risk Factors of Dry Eye Disease: Considerations for Clinical Management. Medicina, 60.","DOI":"10.3390\/medicina60091458"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajo.2017.06.033","article-title":"Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older","volume":"182","author":"Farrand","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification Report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajo.2025.09.035","article-title":"TFOS DEWS III: Executive Summary","volume":"282","author":"Perez","year":"2026","journal-title":"Am. J. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lyngstadaas, A.V., Olsen, M.V., Bair, J.A., Hodges, R.R., Utheim, T.P., Serhan, C.N., and Dartt, D.A. (2021). Pro-Resolving Mediator Annexin A1 Regulates Intracellular Ca2+ and Mucin Secretion in Cultured Goblet Cells Suggesting a New Use in Inflammatory Conjunctival Diseases. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.618653"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10529-017-2326-1","article-title":"The lacrimal gland: Development, wound repair and regeneration","volume":"39","author":"Yao","year":"2017","journal-title":"Biotechnol. Lett."},{"key":"ref_9","first-page":"17","article-title":"Isotretinoinapplikation zur Behandlung der Akne vulgaris. Prospektive Studie \u00fcber Art und Ausmass der okul\u00e4ren Komplikationen [Isotretinoin administration in treatment of acne vulgaris. A prospective study of the kind and extent of ocular complications]","volume":"92","author":"Egger","year":"1995","journal-title":"Ophthalmologe"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ou, S., Zhang, L., Wu, Y., Yang, D., Jiang, N., Mao, T., Zheng, X., Gu, H., and Zhang, L. (2025). Alterations in the composition of meibomian gland secretions in patients with meibomian gland dysfunction based on Raman spectroscopy. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1717118"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.37765\/ajmc.2023.89448","article-title":"Addressing excessive evaporation: An unmet need in dry eye disease","volume":"29","author":"Karpecki","year":"2023","journal-title":"Am. J. Manag. Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.survophthal.2019.08.007","article-title":"Management of meibomian gland dysfunction: A review","volume":"65","author":"Sabeti","year":"2020","journal-title":"Surv. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mansoor, H., Tan, H.C., Lin, M.T., Mehta, J.S., and Liu, Y.C. (2020). Diabetic Corneal Neuropathy. J. Clin. Med., 9.","DOI":"10.3390\/jcm9123956"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/ICO.0b013e31821eea10","article-title":"Ocular disorders due to eyelash extensions","volume":"31","author":"Amano","year":"2012","journal-title":"Cornea"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00417-018-4194-3","article-title":"Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines","volume":"257","author":"Choi","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2017.09.031","article-title":"Botulinum Toxin A for the Treatment of Photophobia and Dry Eye","volume":"125","author":"Diel","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/09286586.2023.2248629","article-title":"Association of Dry Eye Symptoms and Signs in Patients with Dry Eye Disease","volume":"31","author":"Tawfik","year":"2024","journal-title":"Ophthalmic Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ophtha.2016.11.008","article-title":"Predictors of Discordance between Symptoms and Signs in Dry Eye Disease","volume":"124","author":"Vehof","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kawahara, A. (2023). Treatment of Dry Eye Disease (DED) in Asia: Strategies for Short Tear Film Breakup Time-Type DED. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15112591"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/OPX.0000000000001387","article-title":"Impact of Dry Eye on Visual Acuity and Contrast Sensitivity: Dry Eye Assessment and Management Study","volume":"96","author":"Maguire","year":"2019","journal-title":"Optom. Vis. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jtos.2025.02.005","article-title":"The impact of dry eye disease on patient-reported quality of life: A Save Sight Dry Eye Registry study","volume":"37","author":"Kandel","year":"2025","journal-title":"Ocul. Surf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jtos.2023.12.001","article-title":"Dry eye disease in the young: A narrative review","volume":"31","author":"Stapleton","year":"2024","journal-title":"Ocul. Surf."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ghach, W., Bakkar, M.M., Aridi, M., and Alebrahim, M.A. (2025). Symptomatic dry eye disease (DED) in cohort of contact lens wearers in Jordan. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0335254"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.2147\/OPTH.S321591","article-title":"The Relationship Between Dry Eye Disease and Digital Screen Use","volume":"15","author":"Schachter","year":"2021","journal-title":"Clin. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e002014","DOI":"10.1136\/bmjophth-2024-002014","article-title":"Prevalence of dry eye disease among children: A systematic review and meta-analysis","volume":"10","author":"Zou","year":"2025","journal-title":"BMJ Open Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1177\/11206721211060963","article-title":"Dry eye disease and psychiatric disorders: A systematic review and meta-analysis","volume":"32","author":"Basilious","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Villani, E., Barabino, S., Giannaccare, G., Di Zazzo, A., Aragona, P., and Rolando, M. (2025). From Symptoms to Satisfaction: Optimizing Patient-Centered Care in Dry Eye Disease. J. Clin. Med., 14.","DOI":"10.3390\/jcm14010196"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/02713683.2020.1801758","article-title":"Gender-Specific Differences in Signs and Symptoms of Dry Eye Disease","volume":"46","author":"Borrelli","year":"2021","journal-title":"Curr. Eye Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Wu, K., Yu, Y., Shi, J., Chen, H., Xie, C., Tang, Y., and Yao, X. (2025). Relationship between myopia and diagnosis rates of dry eye disease and related indicators: A systematic review and meta-analysis. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1541304"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtos.2024.01.009","article-title":"Association between systemic medication use and severity of dry eye signs and symptoms in the DRy eye assessment and management (DREAM) study","volume":"32","author":"Guo","year":"2024","journal-title":"Ocul. Surf."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"DES7","DOI":"10.1167\/iovs.17-23475","article-title":"Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions","volume":"59","author":"Shimazaki","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Tsubota, K., Pflugfelder, S.C., Liu, Z., Baudouin, C., Kim, H.M., Messmer, E.M., Kruse, F., Liang, L., Carreno-Galeano, J.T., and Rolando, M. (2020). Defining Dry Eye from a Clinical Perspective. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239271"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40123-025-01261-5","article-title":"A Narrative Review on the Diagnosis of Dry Eye Disease: Insights from the Italian Dry Eye Consensus (IDEC) Group","volume":"15","author":"Fasciani","year":"2025","journal-title":"Ophthalmol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2147\/OPTH.S388289","article-title":"How Can We Best Diagnose Severity Levels of Dry Eye Disease: Current Perspectives","volume":"17","author":"Chester","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.18240\/ijo.2019.10.15","article-title":"New approaches for diagnosis of dry eye disease","volume":"12","author":"Elhusseiny","year":"2019","journal-title":"Int. J. Ophthalmol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Wu, Y., Wang, C., Wang, X., Mou, Y., Yuan, K., Huang, X., and Jin, X. (2022). Advances in Dry Eye Disease Examination Techniques. Front. Med., 8.","DOI":"10.3389\/fmed.2021.826530"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1542-0124(12)70083-6","article-title":"Methodologies to diagnose and monitor dry eye disease: Report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","author":"Bron","year":"2007","journal-title":"Ocul. Surf."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.clae.2018.10.025","article-title":"Lid-parallel conjunctival fold (LIPCOF) morphology imaged by optical coherence tomography and its relationship to LIPCOF grade","volume":"42","author":"Bandlitz","year":"2019","journal-title":"Cont. Lens Anterior Eye"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.1038\/s41598-021-87336-2","article-title":"Evaluation of tear osmolarity measured by I-Pen osmolarity system in patients with dry eye","volume":"11","author":"Park","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100842","DOI":"10.1016\/j.preteyeres.2020.100842","article-title":"Advances in the diagnosis and treatment of dry eye","volume":"78","author":"Kojima","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3509064","DOI":"10.1155\/2020\/3509064","article-title":"Objective Imaging Diagnostics for Dry Eye Disease","volume":"2020","author":"Han","year":"2020","journal-title":"J. Ophthalmol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Barrientos, R.T., God\u00edn, F., Rocha-De-Lossada, C., Soifer, M., S\u00e1nchez-Gonz\u00e1lez, J.M., Moreno-Toral, E., Gonz\u00e1lez, A.L., Zein, M., Larco PJr Mercado, C., and Piedrahita, M.A. (2022). Ophthalmological Approach for the Diagnosis of Dry Eye Disease in Patients with Sj\u00f6gren\u2019s Syndrome. Life, 12.","DOI":"10.3390\/life12111899"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jtos.2021.11.004","article-title":"Artificial intelligence in dry eye disease","volume":"23","author":"Riegler","year":"2022","journal-title":"Ocul. Surf."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1038\/s41598-023-33021-5","article-title":"Artificial intelligence to estimate the tear film breakup time and diagnose dry eye disease","volume":"13","author":"Shimizu","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Yang, H.K., Che, S.A., Hyon, J.Y., and Han, S.B. (2022). Integration of Artificial Intelligence into the Approach for Diagnosis and Monitoring of Dry Eye Disease. Diagnostics, 12.","DOI":"10.3390\/diagnostics12123167"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/joco.joco_172_24","article-title":"Artificial Intelligence in Clinical Diagnosis and Treatment of Dry Eye: Workflows, Effectiveness, and Evaluation","volume":"36","author":"Lu","year":"2025","journal-title":"J. Curr. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II Management and Therapy Report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Harti, M.E., Andaloussi, S.J., and Ouchetto, O. (2025). A Comprehensive Review Comparing Artificial Intelligence and Clinical Diagnostic Approaches for Dry Eye Disease. Diagnostics, 15.","DOI":"10.3390\/diagnostics15233071"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Costin, H.-N., Fira, M., and Gora\u0219, L. (2025). Artificial Intelligence in Ophthalmology: Advantages and Limits. Appl. Sci., 15.","DOI":"10.3390\/app15041913"},{"key":"ref_50","first-page":"e70056","article-title":"Artificial Intelligence in Dry Eye Disease: A Narrative Review","volume":"16","author":"Nair","year":"2024","journal-title":"Cureus"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/OPTH.S228838","article-title":"Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies","volume":"14","author":"Kabat","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/bjophthalmol-2019-315747","article-title":"Modern approach to the treatment of dry eye, a complex multifactorial disease: A P.I.C.A.S.S.O. board review","volume":"105","author":"Aragona","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_53","first-page":"CD009729","article-title":"Over the counter (OTC) artificial tear drops for dry eye syndrome","volume":"2","author":"Pucker","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kathuria, A., Shamloo, K., Jhanji, V., and Sharma, A. (2021). Categorization of Marketed Artificial Tear Formulations Based on Their Ingredients: A Rational Approach for Their Use. J. Clin. Med., 10.","DOI":"10.3390\/jcm10061289"},{"key":"ref_55","first-page":"71","article-title":"The pathophysiology, diagnosis, and treatment of dry eye disease","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.icu.0000512373.81749.b7","article-title":"Dysfunctional tear syndrome: Dry eye disease and associated tear film disorders-new strategies for diagnosis and treatment","volume":"27","author":"Milner","year":"2017","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Bian, X., Ma, J., Liu, Y., Feng, Y., Liu, Z., Zhang, B., and Huang, B. (2025). Cyclosporine a in the treatment of dry eye disease: A narrative review. Front. Ophthalmol., 5.","DOI":"10.3389\/fopht.2025.1700163"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1167\/iovs.05-1281","article-title":"Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline","volume":"47","author":"Corrales","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_59","first-page":"2515841418783622","article-title":"An eye for azithromycin: Review of the literature","volume":"10","author":"Kagkelaris","year":"2018","journal-title":"Ther. Adv. Ophthalmol."},{"key":"ref_60","first-page":"e1","article-title":"Systemic antibiotic treatment for meibomian gland dysfunction-A systematic review and meta-analysis","volume":"102","author":"Chan","year":"2024","journal-title":"Acta Ophthalmol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Li, J.X., Tsai, Y.Y., Lai, C.T., Li, Y.L., Wu, Y.H., and Chiang, C.C. (2022). Lifitegrast Ophthalmic Solution 5% Is a Safe and Efficient Eyedrop for Dry Eye Disease: A Systematic Review and Meta-Analysis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11175014"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2147\/OPTH.S296510","article-title":"Real-World Experience with Lifitegrast Ophthalmic Solution (Xiidra\u00ae) in the US and Canada: Retrospective Study of Patient Characteristics, Treatment Patterns, and Clinical Effectiveness in 600 Patients with Dry Eye Disease","volume":"15","author":"Hovanesian","year":"2021","journal-title":"Clin. Ophthalmol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0976-500X.195920","article-title":"Lifitegrast: A novel drug for treatment of dry eye disease","volume":"7","author":"Abidi","year":"2016","journal-title":"J. Pharmacol. Pharmacother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/jop.2017.0052","article-title":"Relevance of Lipid-Based Products in the Management of Dry Eye Disease","volume":"33","author":"Garrigue","year":"2017","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.12659\/MSM.891364","article-title":"Omega-3 essential fatty acids therapy for dry eye syndrome: A meta-analysis of randomized controlled studies","volume":"20","author":"Liu","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jamaophthalmol.2022.1818","article-title":"Efficacy of Marine \u03c9-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial","volume":"140","author":"Christen","year":"2022","journal-title":"JAMA Ophthalmol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ophtha.2016.09.025","article-title":"Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3)","volume":"124","author":"Holland","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cct.2018.06.002","article-title":"Dry Eye Assessment and Management (DREAM\u00a9) Study: Study design and baseline characteristics","volume":"71","author":"Asbell","year":"2018","journal-title":"Contemp. Clin. Trials."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9312340","DOI":"10.1155\/2016\/9312340","article-title":"Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease","volume":"2016","author":"Jehangir","year":"2016","journal-title":"J. Ophthalmol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/tjo.tjo_5_20","article-title":"Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis","volume":"10","author":"Mead","year":"2020","journal-title":"Taiwan J. Ophthalmol."},{"key":"ref_72","first-page":"10","article-title":"Performing a tarsorrhaphy","volume":"28","author":"Rajak","year":"2015","journal-title":"Community Eye Health"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICU.0000000000000569","article-title":"Advances in dry eye disease treatment","volume":"30","author":"Henderson","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.4103\/IJO.IJO_2987_22","article-title":"Efficacy of intense pulsed light therapy on signs and symptoms of dry eye disease: A meta-analysis and systematic review","volume":"71","author":"Qin","year":"2023","journal-title":"Indian J. Ophthalmol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"14997","DOI":"10.1038\/ncomms14997","article-title":"Wearable smart sensor systems integrated on soft contact lenses for wireless ocular diagnostics","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1038\/s41467-018-04781-w","article-title":"Soft transparent graphene contact lens electrodes for conformal full-cornea recording of electroretinogram","volume":"9","author":"Yin","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/A:1026103804104","article-title":"A Glucose Sensing Contact Lens: A Non-Invasive Technique for Continuous Physiological Glucose Monitoring","volume":"13","author":"Badugu","year":"2003","journal-title":"J. Fluoresc."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1038\/s41467-024-47123-9","article-title":"In-depth correlation analysis between tear glucose and blood glucose using a wireless smart contact lens","volume":"15","author":"Park","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e2110536","DOI":"10.1002\/adma.202110536","article-title":"Bimetallic Nanocatalysts Immobilized in Nanoporous Hydrogels for Long-Term Robust Continuous Glucose Monitoring of Smart Contact Lens","volume":"34","author":"Kim","year":"2022","journal-title":"Adv. Mater."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1038\/s41467-022-29860-x","article-title":"Intelligent wireless theranostic contact lens for electrical sensing and regulation of intraocular pressure","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1900728","DOI":"10.1002\/admt.201900728","article-title":"Recent Advances in Smart Contact Lenses","volume":"5","author":"Kim","year":"2020","journal-title":"Adv. Mater. Technol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1021\/acsabm.1c00267","article-title":"Smart Contact Lenses with a Transparent Silver Nanowire Strain Sensor for Continuous Intraocular Pressure Monitoring","volume":"4","author":"Kim","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"18375","DOI":"10.1021\/acsami.0c02991","article-title":"Highly Transparent and Sensitive Graphene Sensors for Continuous and Non-invasive Intraocular Pressure Monitoring","volume":"12","author":"Xu","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"032005","DOI":"10.1088\/2631-7990\/acdc66","article-title":"Recent advances in nanofiber-based flexible transparent electrodes","volume":"5","author":"Zhang","year":"2023","journal-title":"Int. J. Extrem. Manuf."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2024.03.040","article-title":"An adaptive drug-releasing contact lens for personalized treatment of ocular infections and injuries","volume":"369","author":"Sun","year":"2024","journal-title":"J. Control. Release"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"eaba3252","DOI":"10.1126\/sciadv.aba3252","article-title":"Wireless smart contact lens for diabetic diagnosis and therapy","volume":"6","author":"Keum","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2147\/OPTH.S109708","article-title":"The Sensimed Triggerfish contact lens sensor: Efficacy, safety, and patient perspectives","volume":"11","author":"Dunbar","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1021\/acs.chemrev.3c00290","article-title":"Smart Contact Lenses as Wearable Ophthalmic Devices for Disease Monitoring and Health Management","volume":"123","author":"Seo","year":"2023","journal-title":"Chem. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1109\/JBHI.2016.2594058","article-title":"Toward a Wirelessly Powered On-Lens Intraocular Pressure Monitoring System","volume":"20","author":"Chiou","year":"2016","journal-title":"IEEE J. Biomed. Health Inf."},{"key":"ref_90","unstructured":"(2019). IEEE Standard for Safety Levels with Respect to Human Exposure to Electric, Magnetic, and Electromagnetic Fields, 0 Hz to 300 GHz (Standard No. C95.1-2005)."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"eaay0764","DOI":"10.1126\/sciadv.aay0764","article-title":"Printing of wirelessly rechargeable solid-state supercapacitors for soft, smart contact lenses with continuous operations","volume":"5","author":"Park","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nanoen.2018.08.054","article-title":"Scalable fabrication of flexible thin-film batteries for smart lens applications","volume":"53","author":"Lee","year":"2018","journal-title":"Nano Energy"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1021\/acs.nanolett.0c04362","article-title":"Tear-Based Aqueous Batteries for Smart Contact Lenses Enabled by Prussian Blue Analogue Nanocomposites","volume":"21","author":"Yun","year":"2021","journal-title":"Nano Lett."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-018-0536-x","article-title":"Self-powered ultra-flexible electronics via nano-grating-patterned organic photovoltaics","volume":"561","author":"Park","year":"2018","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41528-022-00211-6","article-title":"Flexible organic integrated electronics for self-powered multiplexed ocular monitoring","volume":"6","author":"Lin","year":"2022","journal-title":"npj Flex. Electron."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"nwac170","DOI":"10.1093\/nsr\/nwac170","article-title":"Triboelectric nanogenerators as wearable power sources and self-powered sensors","volume":"10","author":"Pu","year":"2022","journal-title":"Natl. Sci. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e2401068","DOI":"10.1002\/smll.202401068","article-title":"Power Scavenging Microsystem for Smart Contact Lenses","volume":"20","author":"Pourshaban","year":"2024","journal-title":"Small"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/OPX.0000000000000763","article-title":"The Use of Contact Lenses as Biosensors","volume":"93","author":"Phan","year":"2016","journal-title":"Optom. Vis. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"114582","DOI":"10.1016\/j.addr.2022.114582","article-title":"Novel drug delivery systems for the management of dry eye","volume":"191","author":"Nagai","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/tvst.7.5.24","article-title":"Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye Disease","volume":"7","author":"Coursey","year":"2018","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jphp.12075","article-title":"Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery","volume":"66","author":"Daull","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.09.016","article-title":"Vesicular systems in ocular drug delivery: An overview","volume":"269","author":"Kaur","year":"2004","journal-title":"Int. J. Pharm."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ICO.0b013e31821b71e6","article-title":"Effectiveness of artificial tears in the management of evaporative dry eye","volume":"31","author":"McCann","year":"2012","journal-title":"Cornea"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/jop.2015.0032","article-title":"Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease","volume":"32","author":"Fonzar","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/chem.201504355","article-title":"A Divalent PAMAM-Based Matrix Metalloproteinase\/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome","volume":"22","author":"Richichi","year":"2016","journal-title":"Chemistry"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Tawfik, S.M., Azizov, S., Elmasry, M.R., Sharipov, M., and Lee, Y.I. (2020). Recent Advances in Nanomicelles Delivery Systems. Nanomaterials, 11.","DOI":"10.3390\/nano11010070"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.2147\/IJN.S173691","article-title":"Stability, safety, and transcorneal mechanistic studies of ophthalmic lyophilized cyclosporine-loaded polymeric micelles","volume":"13","author":"Shen","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11095-018-2556-5","article-title":"Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa\u00ae) for Dry Eye Disease","volume":"36","author":"Mandal","year":"2019","journal-title":"Pharm. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3109\/17435390.2016.1153165","article-title":"Safety and toxicity of nanomaterials for ocular drug delivery applications","volume":"10","author":"Mehra","year":"2016","journal-title":"Nanotoxicology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2015.07.007","article-title":"Dexamethasone nanowafer as an effective therapy for dry eye disease","volume":"213","author":"Coursey","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/nn506599f","article-title":"Ocular drug delivery nanowafer with enhanced therapeutic efficacy","volume":"9","author":"Yuan","year":"2015","journal-title":"ACS Nano"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.4103\/IJO.IJO_2806_22","article-title":"Newer approaches to dry eye therapy: Nanotechnology, regenerative medicine, and tissue engineering","volume":"71","author":"Joshi","year":"2023","journal-title":"Indian J. Ophthalmol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clae.2015.08.003","article-title":"Complications and fitting challenges associated with scleral contact lenses: A review","volume":"39","author":"Walker","year":"2016","journal-title":"Cont. Lens Anterior Eye"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Chen, J., Bai, T., Su, J., Cong, X., Lv, L., Tong, L., Yu, H., Feng, Y., and Yu, G. (2024). Salivary Gland Transplantation as a Promising Approach for Tear Film Restoration in Severe Dry Eye Disease. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020521"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/14712598.2023.2175605","article-title":"Applications of mesenchymal stem cells in ocular surface diseases: Sources and routes of delivery","volume":"23","author":"Soleimani","year":"2023","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"9636897221133818","DOI":"10.1177\/09636897221133818","article-title":"Mesenchymal Stromal Cell-Based Therapy for Dry Eye: Current Status and Future Perspectives","volume":"31","author":"Jiang","year":"2022","journal-title":"Cell Transpl."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Sanabria-de la Torre, R., Qui\u00f1ones-Vico, M.I., Fern\u00e1ndez-Gonz\u00e1lez, A., S\u00e1nchez-D\u00edaz, M., Montero-V\u00edlchez, T., Sierra-S\u00e1nchez, \u00c1., and Arias-Santiago, S. (2021). Alloreactive Immune Response Associated to Human Mesenchymal Stromal Cells Treatment: A Systematic Review. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132991"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Awad, H., Abas, M., Elgharably, H., Tripathi, R., Theofilos, T., Bhandary, S., Sai-Sudhakar, C., Sen, C.K., and Roy, S. (2012). Endogenous opioids in wound-site neutrophils of sternotomy patients. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047569"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"106206","DOI":"10.1016\/j.ejps.2022.106206","article-title":"Current trends in pharmaceutical treatment of dry eye disease: A review","volume":"175","author":"Mohamed","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2147\/OPTH.S115098","article-title":"Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye","volume":"12","author":"Deveney","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejpb.2017.03.006","article-title":"Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts","volume":"117","author":"Lallemand","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/7\/2535\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:21:42Z","timestamp":1774534902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/7\/2535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":122,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["jcm15072535"],"URL":"https:\/\/doi.org\/10.3390\/jcm15072535","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]}}}